Johnson & Johnson
JNJ
#20
Rank
A$786.22 B
Marketcap
A$326.33
Share price
-0.02%
Change (1 day)
35.87%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): A$16.35

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is A$14.99. In 2024 the company made an earnings per share (EPS) of A$9.61 a decrease over its 2023 EPS that were of A$20.71.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$16.3570.18%
2024A$9.61-53.6%
2023A$20.71111.16%
2022A$9.81-13.84%
2021A$11.3841.81%
2020A$8.03-18.92%
2019A$9.9021.2%
2018A$8.171125.3%
2017A$0.67-92.23%
2016A$8.587.37%
2015A$7.99-4.16%
2014A$8.3318.1%
2013A$7.0624.88%
2012A$5.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$10.57-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$2.47-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.57-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$5.33-64.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$29.46 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.32-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A$9.36-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$11.07-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.90-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.16-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK